Form 8-K - Current report:
SEC Accession No. 0000950137-04-006816
Filing Date
2004-08-16
Accepted
2004-08-16 10:18:10
Documents
3
Period of Report
2004-08-16
Items
Item 12: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT c87625e8vk.htm 8-K 6207
2 PRESS RELEASE c87625exv99w1.htm EX-99.1 6946
3 GRAPHIC c87625biosante.gif GRAPHIC 3484
  Complete submission text file 0000950137-04-006816.txt   18516
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 04976565
SIC: 2836 Biological Products, (No Diagnostic Substances)